Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing - PubMed (original) (raw)
doi: 10.1093/carcin/bgs148. Epub 2012 Apr 17.
Carl Morrison, Liang Wang, Donghai Xiong, Peter Vedell, Peng Cui, Xing Hua, Feng Ding, Yan Lu, Michael James, John D Ebben, Haiming Xu, Alex A Adjei, Karen Head, Jaime W Andrae, Michael R Tschannen, Howard Jacob, Jing Pan, Qi Zhang, Francoise Van den Bergh, Haijie Xiao, Ken C Lo, Jigar Patel, Todd Richmond, Mary-Anne Watt, Thomas Albert, Rebecca Selzer, Marshall Anderson, Jiang Wang, Yian Wang, Sandra Starnes, Ping Yang, Ming You
Affiliations
- PMID: 22510280
- PMCID: PMC3499051
- DOI: 10.1093/carcin/bgs148
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing
Pengyuan Liu et al. Carcinogenesis. 2012 Jul.
Abstract
Lung cancer is the leading cause of cancer-related death, with non-small cell lung cancer (NSCLC) being the predominant form of the disease. Most lung cancer is caused by the accumulation of genomic alterations due to tobacco exposure. To uncover its mutational landscape, we performed whole-exome sequencing in 31 NSCLCs and their matched normal tissue samples. We identified both common and unique mutation spectra and pathway activation in lung adenocarcinomas and squamous cell carcinomas, two major histologies in NSCLC. In addition to identifying previously known lung cancer genes (TP53, KRAS, EGFR, CDKN2A and RB1), the analysis revealed many genes not previously implicated in this malignancy. Notably, a novel gene CSMD3 was identified as the second most frequently mutated gene (next to TP53) in lung cancer. We further demonstrated that loss of CSMD3 results in increased proliferation of airway epithelial cells. The study provides unprecedented insights into mutational processes, cellular pathways and gene networks associated with lung cancer. Of potential immediate clinical relevance, several highly mutated genes identified in our study are promising druggable targets in cancer therapy including ALK, CTNNA3, DCC, MLL3, PCDHIIX, PIK3C2B, PIK3CG and ROCK2.
Figures
Fig. 1.
Significantly mutated genes in lung cancer. Red circles represent genes mutated in both ADC and SCC; blue circles represent genes mutated only in ADC and green circles represent genes mutated only in SCC. P values represent the evidence of a gene having higher mutation rate than its background mutation rate. The new Poisson model for mutational process was described in
Supplementary data
.
Fig. 2.
Direct interaction networks. (A) Frequently mutated genes observed in both ADC and SCC. (B) ADC-specific genes. (C) SCC-specific genes. Only clusters with visible interactions (not genes of the same complex) are shown. The direct of action is arranged to be mostly from left to right. The color of the edges or connecting lines indicate the type of regulation (activation: green, inhibition: red and unspecified: gray). Arrows indicated the direction of the interaction with the arrow pointing to the gene being acted on. The meaning of the symbols in the network is presented in
Supplementary data
.
Fig. 2.
Direct interaction networks. (A) Frequently mutated genes observed in both ADC and SCC. (B) ADC-specific genes. (C) SCC-specific genes. Only clusters with visible interactions (not genes of the same complex) are shown. The direct of action is arranged to be mostly from left to right. The color of the edges or connecting lines indicate the type of regulation (activation: green, inhibition: red and unspecified: gray). Arrows indicated the direction of the interaction with the arrow pointing to the gene being acted on. The meaning of the symbols in the network is presented in
Supplementary data
.
Fig. 3.
Knockdown of CSMD3 in airway epithelial cells. (A) Real-time PCR quantitation of CSMD3 transcript levels relative to endogenous levels for pooled populations of cells infection with short-hairpin RNA vectors targeting CSMD3 and selection. All data is normalized to actin signal for each sample. *P = 0.008, **P = 0.001. P values were obtained using two-tailed Student's _t_-test and represent significance of difference from endogenous levels. Error bars represent standard error from the mean. Data points represent triplicate assays. (B) Growth curves of Beas-2b cells with CSMD3 knockdown vectors. Cell viability was determined over 8 days in culture by MTS assay. *P = 0.003, **P = 0.000013. P values were obtained using two-tailed Student's _t_-test and represent significance of difference in Day 6 values from sh1. Error bars represent 1 SD from the mean.
Similar articles
- Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients.
Xiong D, Li G, Li K, Xu Q, Pan Z, Ding F, Vedell P, Liu P, Cui P, Hua X, Jiang H, Yin Y, Zhu Z, Li X, Zhang B, Ma D, Wang Y, You M. Xiong D, et al. Carcinogenesis. 2012 Sep;33(9):1797-805. doi: 10.1093/carcin/bgs210. Epub 2012 Jun 13. Carcinogenesis. 2012. PMID: 22696596 Free PMC article. - Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
La Fleur L, Falk-Sörqvist E, Smeds P, Berglund A, Sundström M, Mattsson JS, Brandén E, Koyi H, Isaksson J, Brunnström H, Nilsson M, Micke P, Moens L, Botling J. La Fleur L, et al. Lung Cancer. 2019 Apr;130:50-58. doi: 10.1016/j.lungcan.2019.01.003. Epub 2019 Jan 9. Lung Cancer. 2019. PMID: 30885352 - Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing.
Shajani-Yi Z, de Abreu FB, Peterson JD, Tsongalis GJ. Shajani-Yi Z, et al. Neoplasia. 2018 Mar;20(3):256-262. doi: 10.1016/j.neo.2017.12.005. Epub 2018 Feb 16. Neoplasia. 2018. PMID: 29454261 Free PMC article. - Management and future directions in non-small cell lung cancer with known activating mutations.
Gerber DE, Gandhi L, Costa DB. Gerber DE, et al. Am Soc Clin Oncol Educ Book. 2014:e353-65. doi: 10.14694/EdBook_AM.2014.34.e353. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857124 Review. - Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
Friedlaender A, Banna G, Malapelle U, Pisapia P, Addeo A. Friedlaender A, et al. Front Oncol. 2019 Mar 19;9:166. doi: 10.3389/fonc.2019.00166. eCollection 2019. Front Oncol. 2019. PMID: 30941314 Free PMC article. Review.
Cited by
- Deciphering the Impact of Rare Missense Variants in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer through Whole Exome Sequencing: A Computational Approach.
Balasundaram A, C Doss GP. Balasundaram A, et al. ACS Omega. 2024 Mar 25;9(14):16288-16302. doi: 10.1021/acsomega.3c10229. eCollection 2024 Apr 9. ACS Omega. 2024. PMID: 38617633 Free PMC article. - Identification and validation of tryptophan metabolism-related lncRNAs in lung adenocarcinoma prognosis and immune response.
Gao M, Wang M, Chen Y, Wu J, Zhou S, He W, Shu Y, Wang X. Gao M, et al. J Cancer Res Clin Oncol. 2024 Apr 1;150(4):171. doi: 10.1007/s00432-024-05665-x. J Cancer Res Clin Oncol. 2024. PMID: 38558328 Free PMC article. - Variant Analysis of miRNA Regulatory Genes in 35 Sporadic Lung Carcinoma Tumors.
Bağcı Ö, Özdemir EM, Şanlıtürk B. Bağcı Ö, et al. Dokl Biochem Biophys. 2023 Dec;513(Suppl 1):S1-S7. doi: 10.1134/S1607672924600052. Epub 2024 Mar 12. Dokl Biochem Biophys. 2023. PMID: 38472669 - Bi-allelic variants in DNAH3 cause male infertility with asthenoteratozoospermia in humans and mice.
Meng GQ, Wang Y, Luo C, Tan YM, Li Y, Tan C, Tu C, Zhang QJ, Hu L, Zhang H, Meng LL, Liu CY, Deng L, Lu GX, Lin G, Du J, Tan YQ, Sha Y, Wang L, He WB. Meng GQ, et al. Hum Reprod Open. 2024 Jan 11;2024(1):hoae003. doi: 10.1093/hropen/hoae003. eCollection 2024. Hum Reprod Open. 2024. PMID: 38312775 Free PMC article.
References
- Siegel R, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 2011;61:212–236. - PubMed
- Wistuba II, et al. Molecular genetics of small cell lung carcinoma. Semin. Oncol. 2001;28:3–13. - PubMed
- Mori N, et al. Variable mutations of the RB gene in small-cell lung carcinoma. Oncogene. 1990;5:1713–1717. - PubMed
- Yokomizo A, et al. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene. 1998;17:475–479. - PubMed
Publication types
MeSH terms
Grants and funding
- R01CA80127/CA/NCI NIH HHS/United States
- R01CA113793/CA/NCI NIH HHS/United States
- R01CA84354/CA/NCI NIH HHS/United States
- R01CA134682/CA/NCI NIH HHS/United States
- R01CA129533/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous